Dysregulation of PKC signaling output is evident in disease states, with impaired signaling generally associated with cancer [6] and enhanced signaling associated with neurodegenerative conditions such as Alzheimer's disease (AD) [7,8] and spinocerebellar ataxia type-14 (SCA14) [9]. This evidence concerns the gene PRRT2 and cancer.